PRISM BioLab Co.,LTD (TYO:206A)
Japan flag Japan · Delayed Price · Currency is JPY
83.00
-1.00 (-1.19%)
Nov 18, 2026, 11:09 AM JST

PRISM BioLab Co.,LTD Financials Overview

Millions JPY. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Revenue
518518677.33305.62112.93554
Revenue Growth
-23.52%-23.52%121.63%170.64%-79.62%-
Gross Profit
156156269.76160.5480.31535
Operating Income
-1,119-1,119-774.45-782.39-496.8767
Net Income
-1,183-1,183-833.7-1,050-526.9172
Earnings Per Share
-32.02-32.02-22.82-33.53-19.092.63
EPS Growth
------

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023
Period EndingSep '25 Sep '24 Sep '23
Japan
11069.6368.04
United States of America
523.5219.211.78
Switzerland
43.8316.7912.06
Total
677.33305.62112.93

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Net Cash (Debt)
1,8411,8412,9164,3921,1341,687
Net Cash Growth
-36.86%-36.86%-33.62%287.32%-32.78%-
Net Cash Per Share
49.8349.8379.81140.3041.0861.68
Cash & Investments
1,8411,8412,9164,3921,1341,687

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Operating Cash Flow
---1,468150.14-513.81-
Capital Expenditures
---64.7-205.79-34.59-
Free Cash Flow
---1,533-55.64-548.4-
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Gross Margin
30.12%30.12%39.83%52.53%71.11%96.57%
Operating Margin
-216.02%-216.02%-114.34%-256.00%-439.99%12.09%
Pretax Margin
-227.99%-227.99%-122.73%-342.98%-465.53%13.18%
Profit Margin
-228.38%-228.38%-123.09%-343.41%-466.60%13.00%
FCF Margin
---226.34%-18.21%-485.63%-

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
PS Ratio
6.0711.929.1048.24--